Brown Advisory Inc Repligen Corp Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$170.78 - $208.42 $219,110 - $267,402	1,283 New	1,283 $235,000
Q3 2023 Oct 24, 2023	SELL	$138.78 - $176.51 $26,923 - $34,242	-194 Reduced 11.05%	1,562 $248,000
Q2 2023 Jul 31, 2023	SELL	$138.42 - $180.31 $25,469 - $33,177	-184 Reduced 9.48%	1,756 $248,000
Q1 2023 May 08, 2023	BUY	$154.26 - $198.1 $2,468 - $3,169	16 Added 0.83%	1,940 $326,000
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $487 - $661	3 Added 0.16%	1,924 $325,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $22,940 - $36,638	143 Added 8.04%	1,921 $359,000
Q2 2022 Sep 13, 2022	BUY	$140.68 - $188.02 $175,850 - $235,025	1,250 Added 70.3%	3,028 $492,000
Q1 2022 Nov 14, 2022	SELL	$161.19 - $257.96 $201,487 - $322,450	-1,250 Reduced 41.28%	1,778 $334,000
Q1 2022 May 09, 2022	SELL	$161.19 - $257.96 $161 - $257	-1 Reduced 0.06%	1,778 $334,000
Q4 2021 Jan 27, 2022	SELL	$247.59 - $304.47 $742 - $913	-3 Reduced 0.17%	1,779 $471,000
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $779 - $1,296	4 Added 0.22%	1,782 $515,000
Q2 2021 Jul 29, 2021	SELL	$165.87 - $220.95 $15,923 - $21,211	-96 Reduced 5.12%	1,778 $355,000
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $17,315 - $21,720	96 Added 5.4%	1,874 $364,000
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $263,286 - $367,281	1,778 New	1,778 $341,000
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $207,132 - $266,083	-2,438 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $180,021 - $226,929	2,438 New	2,438 $225,000
Q2 2019 Aug 12, 2019	SELL	$54.2 - $85.95 $358,912 - $569,160	-6,622 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$49.45 - $62.8 $445 - $565	9 Added 0.14%	6,622 $391,000
Q4 2018 Feb 13, 2019	BUY	$48.26 - $68.88 $1,303 - $1,859	27 Added 0.41%	6,613 $348,000
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $96,127 - $121,124	-2,054 Reduced 23.77%	6,586 $366,000
Q2 2018 Aug 10, 2018	BUY	$35.26 - $47.04 $58,989 - $78,697	1,673 Added 24.01%	8,640 $406,000
Q1 2018 Jun 28, 2018	BUY	$30.92 - $37.27 $1,762 - $2,124	57 Added 0.82%	6,967 $252,000
Q1 2018 May 14, 2018	BUY	$30.92 - $37.27 $18,984 - $22,883	614 Added 9.75%	6,910 $250,000
Q4 2017 Feb 12, 2018	SELL	$32.53 - $38.92 $58,326 - $69,783	-1,793 Reduced 22.17%	6,296 $229,000
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $299,131 - $372,579	8,089	8,089 $310,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.09 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$923 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$729 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$235 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$205 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account